Xun Li

发表

Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors.

Jianfeng Zhou, Yuemao Shen, Hua Zhou, 2016, Bioorganic & medicinal chemistry.

Chemotherapeutics for Toxoplasma gondii: Molecular Biotargets, Binding Modes, and Structure-Activity Relationship Investigations.

Wei Hu, Huai-yu Zhou, Xun Li, 2021, Journal of medicinal chemistry.

Gelatinase inhibitors: a patent review (2011-2017)

Xun Li, 2018, Expert opinion on therapeutic patents.

Discovery of monoamine oxidase inhibitors by medicinal chemistry approaches.

Xun Li, Renyuan Hong, 2019, MedChemComm.

Design, Synthesis, and Preliminary Activity Evaluation of Novel Peptidomimetics as Aminopeptidase N/CD13 Inhibitors

Lei Zhang, Wenfang Xu, Xun Li, 2011, Archiv der Pharmazie.

Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469.

Chen Li, Wei Hu, Chen Li, 2016, European journal of medicinal chemistry.

Design, synthesis and anti-HIV-1 evaluation of hydrazide-based peptidomimetics as selective gelatinase inhibitors.

Yong-tang Zheng, Ruirui Wang, Liu-meng Yang, 2016, Bioorganic & medicinal chemistry.

Protein-protein interface mimicry by an oxazoline piperidine-2,4-dione.

K. Burgess, Xun Li, Dongyue Xin, 2015, Organic letters.

Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).

Ji-feng Wu, Xun Li, 2010, Recent patents on anti-cancer drug discovery.

Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.

Xun Li, Jin-pei Li, 2010, Mini reviews in medicinal chemistry.

Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part I).

Wenfang Xu, Ji-feng Wu, Xun Li, 2009, Bioorganic & medicinal chemistry.

Design, synthesis, bioevaluation of LFC- and PA-tethered anthraquinone analogues of mitoxantrone.

Xun Li, Zhaopeng Liu, Xin-Wen Xie, 2020, Bioorganic chemistry.

Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect.

Jianfeng Zhou, Yuemao Shen, Leilei Shi, 2016, Current medicinal chemistry.

E17 exerts anti-tumor activity through inhibiting topo II-mediated chromosomes condensation in CRC cells.

Chunhua Lu, Xun Li, Xing-Kang Wu, 2019, Biochemical and biophysical research communications.

Discovery of Novel Topoisomerase II Inhibitors by Medicinal Chemistry Approaches.

Wei Hu, Yong-tang Zheng, Zhiyuan Li, 2018, Journal of medicinal chemistry.

Bacillus licheniformis escapes from Myxococcus xanthus predation by deactivating myxovirescin A through enzymatic glucosylation.

Zhi-feng Li, Wei Hu, Chuandong Wang, 2019, Environmental microbiology.

Structure-activity relationship of novel acridone derivatives as antiproliferative agents.

Chunhua Lu, Xun Li, Ji-Ning Chen, 2020, Bioorganic & medicinal chemistry.

Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).

Wenfang Xu, Yazhou Wang, Ji-feng Wu, 2009, Bioorganic & medicinal chemistry.

An updated patent therapeutic agents targeting MMPs.

Xun Li, Lei Shi, Jin-pei Li, 2012, Recent patents on anti-cancer drug discovery.